SOLOIST-WHF (Completed)
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study
to Evaluate the Effects of SOtagLiflozin on Clinical Outcomes in HemOdynamIcally
STable Patients with Type 2 Diabetes POST Worsening Heart Failure
- Medicine
- sotagliflozin
- Population
- Heart failure
- Phase
- III
- Starting year
- 2017
- More information
- Clinicaltrials.gov